Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
And in our report of prostacyclin, the "prostacyclin" means the drugs used for the treatment of pulmonary arterial hypertension.
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.
According to this study, over the next five years the Prostacyclin market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2420 million by 2024, from US$ 1760 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostacyclin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostacyclin market by product type, application, key manufacturers and key regions and countries.
This study considers the Prostacyclin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
For Injection
For Oral
For Inhalation
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostacyclin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Prostacyclin market by identifying its various subsegments.
Focuses on the key global Prostacyclin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostacyclin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostacyclin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
